Integrated NeutroDrop-enabled single-cell ROS-NE droplet biosensing for sepsis auxiliary diagnosis and survival prediction.
Abstract
Sepsis assessment relies largely on organ-dysfunction scores and systemic biomarkers, which provide limited information on immune-effector function. We developed NeutroDrop, an integrated droplet microfluidic platform for single-cell profiling of neutrophil reactive oxygen species (ROS)-related oxidative activity and neutrophil elastase (NE)-associated proteolytic activity. Under standardized fMLP stimulation, individual neutrophils were co-encapsulated with fluorescent probes in monodisperse droplets, while membrane-integrity screening and software-assisted image analysis excluded multicell and membrane-compromised droplets. The study included 1012 neutrophils from 10 healthy controls and 2353 neutrophils from 20 patients with sepsis. Analysis of patient-level median signals showed reduced NE activity in sepsis (group means, 28.91 vs. 72.32), whereas ROS showed a nonsignificant decrease (72.14 vs. 92.26). Healthy-reference single-cell analysis revealed marked depletion of high ROS/high NE neutrophils in sepsis (2.89% vs. 16.86%), leading to the PerHighHigh index for healthy/sepsis classification. Local abundance analysis identified a data-derived low-amplitude ROS-NE region associated with non-survival; its patient-level abundance, Pi(R), stratified 12-day outcome with 83.33% sensitivity and 92.85% specificity in the discovery cohort. These locked rules were implemented in NeutroDrop-Plus, which correctly classified all 10 operator-blinded samples and matched 12-day outcomes in 5 of 6 sepsis cases. NeutroDrop converts neutrophil single-cell functional heterogeneity into quantitative biosensing indicators for adjunctive sepsis classification and exploratory short-term outcome stratification.